Veličković-Radovanović, Radmila

Link to this page

Authority KeyName Variants
6b726eb1-f557-452f-a40b-382d09154322
  • Veličković-Radovanović, Radmila (2)
Projects

Author's Bibliography

Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria

Jovanović, Marija; Kovačević, Milena; Catić-Đorđević, Aleksandra; Ćulafić, Milica; Stefanović, Nikola; Mitić, Branka; Vučićević, Katarina; Vezmar-Kovačević, Sandra; Veličković-Radovanović, Radmila; Miljković, Branislava

(2023)

TY  - JOUR
AU  - Jovanović, Marija
AU  - Kovačević, Milena
AU  - Catić-Đorđević, Aleksandra
AU  - Ćulafić, Milica
AU  - Stefanović, Nikola
AU  - Mitić, Branka
AU  - Vučićević, Katarina
AU  - Vezmar-Kovačević, Sandra
AU  - Veličković-Radovanović, Radmila
AU  - Miljković, Branislava
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4921
AB  - The study aimed to estimate and compare the prevalence and type of potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs) between the STOPP/START original (v1) and updated version (v2) among older patients in various settings, as well as associated factors. The study included 440 patients attending a community pharmacy, 200 outpatients and 140 nursing home users. An increase in the prevalence of STOPP v2 (57.9%) compared to v1 (56.2%) was not statistically significant in the total sample and within each setting (p>0.05). A decrease in the prevalence of START v1 (55.8%) to v2 (41.2%) was statistically significant (p<0.001) in the total sample and within each setting (p<0.05). Drug indication (32.9%) and fall-risk medications (32.2%) were most commonly identified for STOPP v2, while cardiovascular system criteria (30.5%) were the most frequently detected for START v2. The number of medications was the strongest predictor for both STOPP v1 and v2, with odds ratio values of 1.35 and 1.34, respectively. Patients’ characteristics associated with the occurrence of STOPP and START criteria were identified. According to both STOPP/START versions, the results indicate a substantial rate of potentially inappropriate prescribing among elderly patients. The prevalence of PIMs was slightly higher with the updated version, while the prevalence of PPOs was significantly lower.
T2  - Brazilian Journal of Pharmaceutical Sciences
T1  - Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria
VL  - 59
DO  - 10.1590/s2175-97902023e22549
ER  - 
@article{
author = "Jovanović, Marija and Kovačević, Milena and Catić-Đorđević, Aleksandra and Ćulafić, Milica and Stefanović, Nikola and Mitić, Branka and Vučićević, Katarina and Vezmar-Kovačević, Sandra and Veličković-Radovanović, Radmila and Miljković, Branislava",
year = "2023",
abstract = "The study aimed to estimate and compare the prevalence and type of potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs) between the STOPP/START original (v1) and updated version (v2) among older patients in various settings, as well as associated factors. The study included 440 patients attending a community pharmacy, 200 outpatients and 140 nursing home users. An increase in the prevalence of STOPP v2 (57.9%) compared to v1 (56.2%) was not statistically significant in the total sample and within each setting (p>0.05). A decrease in the prevalence of START v1 (55.8%) to v2 (41.2%) was statistically significant (p<0.001) in the total sample and within each setting (p<0.05). Drug indication (32.9%) and fall-risk medications (32.2%) were most commonly identified for STOPP v2, while cardiovascular system criteria (30.5%) were the most frequently detected for START v2. The number of medications was the strongest predictor for both STOPP v1 and v2, with odds ratio values of 1.35 and 1.34, respectively. Patients’ characteristics associated with the occurrence of STOPP and START criteria were identified. According to both STOPP/START versions, the results indicate a substantial rate of potentially inappropriate prescribing among elderly patients. The prevalence of PIMs was slightly higher with the updated version, while the prevalence of PPOs was significantly lower.",
journal = "Brazilian Journal of Pharmaceutical Sciences",
title = "Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria",
volume = "59",
doi = "10.1590/s2175-97902023e22549"
}
Jovanović, M., Kovačević, M., Catić-Đorđević, A., Ćulafić, M., Stefanović, N., Mitić, B., Vučićević, K., Vezmar-Kovačević, S., Veličković-Radovanović, R.,& Miljković, B.. (2023). Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria. in Brazilian Journal of Pharmaceutical Sciences, 59.
https://doi.org/10.1590/s2175-97902023e22549
Jovanović M, Kovačević M, Catić-Đorđević A, Ćulafić M, Stefanović N, Mitić B, Vučićević K, Vezmar-Kovačević S, Veličković-Radovanović R, Miljković B. Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria. in Brazilian Journal of Pharmaceutical Sciences. 2023;59.
doi:10.1590/s2175-97902023e22549 .
Jovanović, Marija, Kovačević, Milena, Catić-Đorđević, Aleksandra, Ćulafić, Milica, Stefanović, Nikola, Mitić, Branka, Vučićević, Katarina, Vezmar-Kovačević, Sandra, Veličković-Radovanović, Radmila, Miljković, Branislava, "Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria" in Brazilian Journal of Pharmaceutical Sciences, 59 (2023),
https://doi.org/10.1590/s2175-97902023e22549 . .
1
1

Development and validation of a solid phase extraction-HPLC method for the determination of carbamazepine and its metabolites, carbamazepine epoxide and carbamazepine trans-diol, in plasma

Džodić, Predrag; Živanović, Ljiljana; Protić, Ana; Ivanović, Ivana; Veličković-Radovanović, Radmila; Spasić, Mirjana; Lukić, Stevo; Živanović, Slavoljub

(Srpsko hemijsko društvo, Beograd, 2012)

TY  - JOUR
AU  - Džodić, Predrag
AU  - Živanović, Ljiljana
AU  - Protić, Ana
AU  - Ivanović, Ivana
AU  - Veličković-Radovanović, Radmila
AU  - Spasić, Mirjana
AU  - Lukić, Stevo
AU  - Živanović, Slavoljub
PY  - 2012
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1823
AB  - A solid phase extraction-HPLC method has been developed and validated for the rapid analysis of carbamazepine and its two metabolites, carbamazepine epoxide and carbamazepine trans-diol, in human plasma. The analysis was performed using a C18 Bakerbond-BDC analytical column (250 mm×4.6 mm i.d., particle size 5 μm). The optimal conditions for the separation were established with the mobile phase acetonitrile - 10 mM phosphate buffer, pH 7.0 (30:70, v/v) at a flow rate of 1.5 mL min-1 and temperature of 35°C, with UV detection at 210 nm. The total run time was about 8 minutes. The SPE procedure for the extraction of the analytes from a plasma sample was developed using Oasis HLB cartridges and subsequently, the eluate was injected into the HPLC system for analysis. Afterwards, the SPE-HPLC method was subjected to validation. Linearity was obtained over the concentration range of 0.2-25 μg mL-1 for carbamazepine, carbamazepine epoxide and carbamazepine trans-diol, with correlation coefficients higher than 0.995. The method showed good intra-day and inter-day precision with a relative standard deviation below 7.96 %, while the accuracy ranged from 92.09 to 108.5 % for all analytes. Finally, the method was successfully applied to the analysis of the plasma samples of epileptic patients in mono- and polytherapy.
AB  - SPE-HPLC metoda je razvijena i validirana u cilju brzog analiziranja karbamazepina i metabolita karbamazepin epoksida i karbamazepin trans-diola u humanoj plazmi. C18 Bakerbond-BDC analitička kolona (250 mm x 4,6 mm; 5 μm) je korišćena radi izvođenja analize. Optimalni uslovi za hromatografsko razdvajanje su mobilna faza acetonitril - 10 mM fosfatni pufer, pH 7,0 (30:70, v/v), protok od 1,5 ml min-1, temperatura 35°C i detekcija na 210 nm. Ukupno trajanje hromatografskog rana iznosi oko 8 min. SPE procedura za ekstrakciju analita iz uzoraka plazme je razvijena uz korišćenje Oasis HLB ketridža nakon čega se eluat injektuje u HPLC sistem radi analiziranja. Zatim je izvršena validacija SPE-HPLC metode. Linearnost je potvrđena u koncentracionom opsegu 0,2-25 μg/ml za karbamazepin, karbamazepin epoksid i karbamazepin trans-diol sa vrednošću korelacionih koeficijenata višom od 0,995. Preciznost metode u toku jednog i u toku više dana je dobra sa relativnom standardnom devijacijom nižom od 7,96 %, dok tačnost metode obuhvata vrednosti u opsegu od 92,09 do 108,5 % za sve analite. Na kraju je metoda uspešno primenjena u cilju analiziranja uzoraka plazme pacijenata obolelih od epilepsije na monoterapiji i politerapiji.
PB  - Srpsko hemijsko društvo, Beograd
T2  - Journal of the Serbian Chemical Society
T1  - Development and validation of a solid phase extraction-HPLC method for the determination of carbamazepine and its metabolites, carbamazepine epoxide and carbamazepine trans-diol, in plasma
T1  - Razvoj i validacija spe-HPLC metode za određivanje karbamazepina i metabolita karbamazepin epoksida i karbamazepin trans-diola u plazmi
VL  - 77
IS  - 10
SP  - 1423
EP  - 1436
DO  - 10.2298/JSC120106084D
ER  - 
@article{
author = "Džodić, Predrag and Živanović, Ljiljana and Protić, Ana and Ivanović, Ivana and Veličković-Radovanović, Radmila and Spasić, Mirjana and Lukić, Stevo and Živanović, Slavoljub",
year = "2012",
abstract = "A solid phase extraction-HPLC method has been developed and validated for the rapid analysis of carbamazepine and its two metabolites, carbamazepine epoxide and carbamazepine trans-diol, in human plasma. The analysis was performed using a C18 Bakerbond-BDC analytical column (250 mm×4.6 mm i.d., particle size 5 μm). The optimal conditions for the separation were established with the mobile phase acetonitrile - 10 mM phosphate buffer, pH 7.0 (30:70, v/v) at a flow rate of 1.5 mL min-1 and temperature of 35°C, with UV detection at 210 nm. The total run time was about 8 minutes. The SPE procedure for the extraction of the analytes from a plasma sample was developed using Oasis HLB cartridges and subsequently, the eluate was injected into the HPLC system for analysis. Afterwards, the SPE-HPLC method was subjected to validation. Linearity was obtained over the concentration range of 0.2-25 μg mL-1 for carbamazepine, carbamazepine epoxide and carbamazepine trans-diol, with correlation coefficients higher than 0.995. The method showed good intra-day and inter-day precision with a relative standard deviation below 7.96 %, while the accuracy ranged from 92.09 to 108.5 % for all analytes. Finally, the method was successfully applied to the analysis of the plasma samples of epileptic patients in mono- and polytherapy., SPE-HPLC metoda je razvijena i validirana u cilju brzog analiziranja karbamazepina i metabolita karbamazepin epoksida i karbamazepin trans-diola u humanoj plazmi. C18 Bakerbond-BDC analitička kolona (250 mm x 4,6 mm; 5 μm) je korišćena radi izvođenja analize. Optimalni uslovi za hromatografsko razdvajanje su mobilna faza acetonitril - 10 mM fosfatni pufer, pH 7,0 (30:70, v/v), protok od 1,5 ml min-1, temperatura 35°C i detekcija na 210 nm. Ukupno trajanje hromatografskog rana iznosi oko 8 min. SPE procedura za ekstrakciju analita iz uzoraka plazme je razvijena uz korišćenje Oasis HLB ketridža nakon čega se eluat injektuje u HPLC sistem radi analiziranja. Zatim je izvršena validacija SPE-HPLC metode. Linearnost je potvrđena u koncentracionom opsegu 0,2-25 μg/ml za karbamazepin, karbamazepin epoksid i karbamazepin trans-diol sa vrednošću korelacionih koeficijenata višom od 0,995. Preciznost metode u toku jednog i u toku više dana je dobra sa relativnom standardnom devijacijom nižom od 7,96 %, dok tačnost metode obuhvata vrednosti u opsegu od 92,09 do 108,5 % za sve analite. Na kraju je metoda uspešno primenjena u cilju analiziranja uzoraka plazme pacijenata obolelih od epilepsije na monoterapiji i politerapiji.",
publisher = "Srpsko hemijsko društvo, Beograd",
journal = "Journal of the Serbian Chemical Society",
title = "Development and validation of a solid phase extraction-HPLC method for the determination of carbamazepine and its metabolites, carbamazepine epoxide and carbamazepine trans-diol, in plasma, Razvoj i validacija spe-HPLC metode za određivanje karbamazepina i metabolita karbamazepin epoksida i karbamazepin trans-diola u plazmi",
volume = "77",
number = "10",
pages = "1423-1436",
doi = "10.2298/JSC120106084D"
}
Džodić, P., Živanović, L., Protić, A., Ivanović, I., Veličković-Radovanović, R., Spasić, M., Lukić, S.,& Živanović, S.. (2012). Development and validation of a solid phase extraction-HPLC method for the determination of carbamazepine and its metabolites, carbamazepine epoxide and carbamazepine trans-diol, in plasma. in Journal of the Serbian Chemical Society
Srpsko hemijsko društvo, Beograd., 77(10), 1423-1436.
https://doi.org/10.2298/JSC120106084D
Džodić P, Živanović L, Protić A, Ivanović I, Veličković-Radovanović R, Spasić M, Lukić S, Živanović S. Development and validation of a solid phase extraction-HPLC method for the determination of carbamazepine and its metabolites, carbamazepine epoxide and carbamazepine trans-diol, in plasma. in Journal of the Serbian Chemical Society. 2012;77(10):1423-1436.
doi:10.2298/JSC120106084D .
Džodić, Predrag, Živanović, Ljiljana, Protić, Ana, Ivanović, Ivana, Veličković-Radovanović, Radmila, Spasić, Mirjana, Lukić, Stevo, Živanović, Slavoljub, "Development and validation of a solid phase extraction-HPLC method for the determination of carbamazepine and its metabolites, carbamazepine epoxide and carbamazepine trans-diol, in plasma" in Journal of the Serbian Chemical Society, 77, no. 10 (2012):1423-1436,
https://doi.org/10.2298/JSC120106084D . .
9
10
12